CAPPED BONUSZERTIFIKAT - ABBOTT LABORATORIES Stock

Certificat

DE000PC9C5T6

Market Closed - Bid/Ask 02:32:33 2024-06-28 am EDT After market 03:45:17 pm
65.6 EUR +0.05% Intraday chart for CAPPED BONUSZERTIFIKAT - ABBOTT LABORATORIES 65.52 -0.11%
Current month+2.41%
1 month+2.20%
Date Price Change
24-06-28 65.6 +0.05%
24-06-27 65.57 -0.18%
24-06-26 65.69 +0.43%
24-06-25 65.41 -0.20%
24-06-24 65.54 +0.14%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 02:32 am EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC9C5T
ISINDE000PC9C5T6
Date issued 2024-05-08
Strike 75 $
Maturity 2025-12-19 (539 Days)
Parity 1 : 1
Emission price 62.08
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 65.69
Lowest since issue 63.95
Spread 0.05
Spread %0.08%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104.6 USD
Average target price
125.2 USD
Spread / Average Target
+19.60%
Consensus